ConductScience.org, home

Paper37101592

Antithrombotic Effects of the Novel Small-Molecule Factor XIa Inhibitor Milvexian in a Rabbit Arteriovenous Shunt Model of Venous Thrombosis.

Wang X and 5 others. TH Open, 2023. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Antithrombotic Effects of the Novel Small-Molecule Factor XIa Inhibitor Milvexian in a Rabbit Arteriovenous Shunt Model of Venous Thrombosis. Papers, record 37101592. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37101592

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antithrombotic Effects of the Novel Small-Molecule Factor XIa Inhibitor Milvexian in a Rabbit Arteriovenous Shunt Model of Venous Thrombosis.
PubMed
Journal
TH Open
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.71
iCite
Revised in PubMed
2023-04-28
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang XXinkanghttps://orcid.org/0000-0001-7780-4494
2Li QQiu
3Du FFuyong
4Shukla NNeetu
5Nawrocki ARAndrea R
6Chintala MMadhu

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130496103Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.Lancet2018https://conductscience.org/library/papers/30496103PubMed
218647224Arterial antithrombotic and bleeding time effects of apixaban, a direct factor Xa inhibitor, in combination with antiplatelet therapy in rabbits.J Thromb Haemost2008https://conductscience.org/library/papers/18647224PubMed
334780683Milvexian for the Prevention of Venous Thromboembolism.N Engl J Med2021https://conductscience.org/library/papers/34780683PubMed
430700128Intrinsic Pathway of Coagulation and Thrombosis.Arterioscler Thromb Vasc Biol2019https://conductscience.org/library/papers/30700128PubMed
534752670Milvexian, an orally bioavailable, small-molecule, reversible, direct inhibitor of factor XIa: In vitro studies and in vivo evaluation in experimental thrombosis in rabbits.J Thromb Haemost2022https://conductscience.org/library/papers/34752670PubMed
625084749Thrombotic safety of prothrombin complex concentrate (Beriplex P/N) for dabigatran reversal in a rabbit model.Thromb Res2014https://conductscience.org/library/papers/25084749PubMed
726249722In vitro, antithrombotic and bleeding time studies of BMS-654457, a small-molecule, reversible and direct inhibitor of factor XIa.J Thromb Thrombolysis2015https://conductscience.org/library/papers/26249722PubMed
816839345Factor XI contributes to thrombus propagation on injured neointima of the rabbit iliac artery.J Thromb Haemost2006https://conductscience.org/library/papers/16839345PubMed
915733058Effects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice.J Thromb Haemost2005https://conductscience.org/library/papers/15733058PubMed
1036768891Thrombosis Models: An Overview of Common In Vivo and In Vitro Models of Thrombosis.Int J Mol Sci2023https://conductscience.org/library/papers/36768891PubMed
119518045A murine model of factor XI deficiency.Blood Coagul Fibrinolysis1997https://conductscience.org/library/papers/9518045PubMed
1218945968Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI.Blood2009https://conductscience.org/library/papers/18945968PubMed
1317362226Antithrombotic and anticoagulant effects of the direct thrombin inhibitor dabigatran, and its oral prodrug, dabigatran etexilate, in a rabbit model of venous thrombosis.J Thromb Haemost2007https://conductscience.org/library/papers/17362226PubMed
1434297496Abelacimab for Prevention of Venous Thromboembolism.N Engl J Med2021https://conductscience.org/library/papers/34297496PubMed
1534494428Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies for Antithrombotic Therapy.J Med Chem2022https://conductscience.org/library/papers/34494428PubMed
1612689935Factor XI-dependence of surface- and tissue factor-initiated thrombus propagation in primates.Blood2003https://conductscience.org/library/papers/12689935PubMed
1728373761Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management.World J Gastroenterol2017https://conductscience.org/library/papers/28373761PubMed
1825976012Factor XI and contact activation as targets for antithrombotic therapy.J Thromb Haemost2015https://conductscience.org/library/papers/25976012PubMed
1910604970Nonpeptide factor Xa inhibitors: I. Studies with SF303 and SK549, a new class of potent antithrombotics.J Pharmacol Exp Ther2000https://conductscience.org/library/papers/10604970PubMed
2010706899High levels of coagulation factor XI as a risk factor for venous thrombosis.N Engl J Med2000https://conductscience.org/library/papers/10706899PubMed

See all 36 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42653793Translational Development of Oral FXIa Inhibitors: A Systematic Review of Molecular Design, Pharmacology, and Indication-Specific Clinical Evidence.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42653793PubMed
41549794A Thorough QT Study to Assess the Effects of Milvexian on Cardiac Repolarization in Healthy Participants.Clin Pharmacol Drug Dev2026https://conductscience.org/library/papers/41549794PubMed
39152241Milvexian: An Oral, Bioavailable Factor XIa Inhibitor.Cardiol Ther2024https://conductscience.org/library/papers/39152241PubMed
38374994Anticoagulants for atrial fibrillation: from warfarin and DOACs to the promise of factor XI inhibitors.Front Cardiovasc Med2024https://conductscience.org/library/papers/38374994PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
F102159PubTator's text mininghttps://conductscience.org/library/genes/2159NCBI Gene
F112160PubTator's text mininghttps://conductscience.org/library/genes/2160NCBI Gene
F22147PubTator's text mininghttps://conductscience.org/library/genes/2147NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37101592

GET https://conductscience.org/api/papers/v1/37101592/references?page=2